Literature DB >> 31478369

Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight Limits.

Fiorella Ruggiu1, Shengtian Yang1, Robert L Simmons1, Anthony Casarez1, Adriana K Jones1, Cindy Li1, Johanna M Jansen1, Heinz E Moser1, Charles R Dean1, Folkert Reck1, Mika Lindvall1.   

Abstract

Monobactam antibiotic 1 is active against Gram-negative bacteria even though it has a higher molecular weight (MW) than the limit of 600 Da typically applied in designing such compounds. On the basis of 2D NMR data, the compound is able to adopt a compact conformation. The dimensions, projection area, and dipole moment derived from this conformation are compatible with porin permeation, as are locations of polar groups upon superimposition to the crystal structure of ampicillin bound to E. coli OmpF porin. Minimum inhibitory concentration (MIC) shifts in a porin knock-out strain are also consistent with 1 predominately permeating through porins. In conclusion, we describe a carefully characterized case of a molecule outside default design parameters where MW does not adequately represent the 3D shape more directly related to permeability. Leveraging 3D design criteria would open up additional chemical space currently underutilized due to limitations perceived in 2D.

Entities:  

Keywords:  conformational flexibility; hydrophobic collapse; permeability; polar surface area; porins

Mesh:

Substances:

Year:  2019        PMID: 31478369     DOI: 10.1021/acsinfecdis.9b00256

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  6 in total

1.  Permeation of β-Lactamase Inhibitors through the General Porins of Gram-Negative Bacteria.

Authors:  Alessandro Pira; Mariano Andrea Scorciapino; Igor V Bodrenko; Andrea Bosin; Silvia Acosta-Gutiérrez; Matteo Ceccarelli
Journal:  Molecules       Date:  2020-12-05       Impact factor: 4.411

2.  Biotinylation as a tool to enhance the uptake of small molecules in Gram-negative bacteria.

Authors:  Ankit Pandeya; Ling Yang; Olaniyi Alegun; Chamikara Karunasena; Chad Risko; Zhenyu Li; Yinan Wei
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

3.  The Optimal Permeation of Cyclic Boronates to Cross the Outer Membrane via the Porin Pathway.

Authors:  Gian Marco Tuveri; Matteo Ceccarelli; Alessandro Pira; Igor V Bodrenko
Journal:  Antibiotics (Basel)       Date:  2022-06-23

4.  The Influence of Permeability through Bacterial Porins in Whole-Cell Compound Accumulation.

Authors:  Silvia Acosta-Gutiérrez; Igor V Bodrenko; Matteo Ceccarelli
Journal:  Antibiotics (Basel)       Date:  2021-05-26

5.  Assessment of the rules related to gaining activity against Gram-negative bacteria.

Authors:  Henni-Karoliina Ropponen; Eleonora Diamanti; Alexandra Siemens; Boris Illarionov; Jörg Haupenthal; Markus Fischer; Matthias Rottmann; Matthias Witschel; Anna K H Hirsch
Journal:  RSC Med Chem       Date:  2021-03-03

Review 6.  Antibiotics in the clinical pipeline in October 2019.

Authors:  Mark S Butler; David L Paterson
Journal:  J Antibiot (Tokyo)       Date:  2020-03-10       Impact factor: 2.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.